K232749 is an FDA 510(k) clearance for the DOOPANG. This device is classified as a Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (Class II - Special Controls, product code PCC).
Submitted by Ybrain, Inc. (Daejeon, KR). The FDA issued a Cleared decision on June 11, 2024, 277 days after receiving the submission on September 8, 2023.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5891. Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin..